TECHNIQUE
Chelation Therapy
The term "chelation" is derived from the Greek word for “claw”, referring to the way chelating agents have an affinity for binding to particular compounds. While the traditional use of chelation is for the treatment of heavy metal poisoning, at Ashland Natural Medicine, we also use intravenous chelation as a part of our cardiovascular treatment regime.
Intravenous Chelation Therapy Benefits and Uses
Chelation therapy involves the intravenous administration of ethylenediaminetetraacetic acid (CaEDTA), or DMPS (2,3-dimercaptopropane-1-sulfonic acid) both synthetic amino acids. When injected into the bloodstream, these compounds bind to heavy metals such as lead, mercury, cadmium, cesium, and arsenic, forming a compound that can be excreted through the urine. This procedure is usually followed by the intravenous administration of glutathione to aid in the process of depuration. The number of sessions varies depending on the amount of metals in the body and a typical chelation session lasts between 60 to 120 minutes.
Before embarking on a course of chelation for the removal of metals we require that a patient have a provoked urine test so we can approximate their metal burden to be able to accurately design an effective program
We have performed thousands of chelation’s safely over the last decade at Ashland Natural Medicine. Helping countless patients overcome the toxic health effects of heavy metals.
FDA-Approved Uses for Intravenous Chelation
The U.S. Food and Drug Administration (FDA) has approved chelation therapy for specific conditions:
Lead poisoning
Heavy metal toxicity (e.g., mercury, arsenic)
Hypercalcemia (excessive calcium level)
Intravenous Chelation Therapy for Cardiovascular Disease
Intravenous chelation is also a safe and effective way to help improve cardiovascular function in patients with atherosclerosis, congestive heart failure, intermittent claudication, shortness of breath, and weakness from diminished heart function.
The most significant study on chelation therapy for cardiovascular disease is the Trial to Assess Chelation Therapy (TACT), funded by the National Institutes of Health. The initial TACT study, published in 2013, showed an overall modest reduction in cardiovascular events in the patients enrolled in the study.
Specifically:
There was a 18% reduction in the risk of cardiovascular events in the overall study population.
Patients with diabetes experienced a more pronounced benefit, with a 41% reduction in the risk of any cardiovascular event and a 43% reduction in the risk of death from any cause
In our clinic, chelation is often combined with Hyperbaric Oxygen Therapy (HBOT) to achieve the fastest results in improving cardiac function.
Two Potent Therapies in One Treatment: Chelazone Infusions
Another powerful treatment used at Ashland Natural Medicine is the pairing of Intravenous Ozone therapy with Intravenous Chelation. Known as “The Chelazone” this therapy allows the benefits of ozone and chelation in one treatment session. The synergistic effects of these two therapies also helps to create a positive healing effect for the cardiovascular system which cannot be obtained with either therapy alone.